8-K: Utah Medical Products Annual Meeting: Director Elected, Auditor Ratified, Executive Pay Approved

Utah Medical Products held its annual meeting on May 2, 2025, where stockholders elected a director, ratified the selection of an accounting firm, and approved executive compensation.

Summary

• Utah Medical Products held its annual meeting of stockholders on May 2, 2025.
• Carrie Leigh was elected as a director of the company with 665,574 votes for, 1,762,500 votes withheld, and 732,568 broker non-votes.
• Haynie & Co. was ratified as the company's independent public accounting firm for the year ended December 31, 2025, with 3,148,121 votes for, 10,548 votes against, and 1,973 abstentions.
• Stockholders approved, on an advisory basis, the compensation paid to UTMD's named executive officers with 2,383,762 votes for, 39,327 votes against, 4,985 abstentions, and 732,568 broker non-votes.
• Carrie Leigh tendered her resignation per company policy, but the Board of Directors voted not to accept it; she will serve a three-year term.
• The company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials until the next required advisory vote on frequency of stockholder votes on executive compensation.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures and shareholder voting outcomes, suggesting a neutral to slightly positive sentiment due to the successful ratification and approval of key items.

Positives

• Stockholders ratified the selection of Haynie & Co. as the company's independent accounting firm.
• Executive compensation was approved on an advisory basis, indicating shareholder support.

Negatives

• A significant number of votes were withheld for the election of Carrie Leigh as director (1,762,500).

Future Outlook

The Company will continue to include annual advisory stockholder votes on executive compensation in its proxy materials until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.

Industry Context

This announcement is a routine disclosure following an annual shareholder meeting, typical for publicly traded companies. It provides transparency regarding key decisions made by shareholders.

Management Changes

Stakeholder Impact

• Shareholders have exercised their voting rights on key company matters.
• The Board of Directors has made decisions regarding director appointments and executive compensation.

Next Steps

• Carrie Leigh will serve a three-year term as director.
• Haynie & Co. will serve as the independent public accounting firm for the year ended December 31, 2025.
• The company will hold future advisory votes on executive compensation.

Key Dates

Keywords

annual meeting, director election, executive compensation, accounting firm, stockholders, UTMD, Utah Medical Products